AGA Medical Inc. (NASDAQ: AGAM) has enrolled the first patient in a clinical trial of a cardiac device aimed at preventing strokes in patients with abnormal heartbeats. CEO John Barr called the first enrollment in the company’s Amplatzer Cardiac Plug trial “a significant milestone” for the company, according to a statement from AGA. The trial […]
Score the final round for device giant Medtronic Inc. in its three-year patent-infringement battle with AGA Medical Inc. over AGA’s Amplatzer cardiac plug. The two companies agreed to end the litigation with AGA paying Medtronic $35 million over four years. The final payment is due in 2014, according to a statement from AGA. In addition, […]
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
AGA Medical has received federal approval to begin a clinical trial of a heart device that’s designed to prevent strokes in patients with abnormal heartbeats. The trial is intended to evaluate the safety and efficacy of the company’s Amplatzer cardiac plug in preventing blood clots in the heart that can lead to strokes. The trial […]